Bergesen Worldwide GAS to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Bergesen Worldwide Gas ASA to listing on the Main List of Oslo Børs. The Board stipulated that prior to the first day of listing the company must, through its planned share issue, satisfy the requirements for the number of holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001. Admission to listing is also conditional on at least 25% of the shares to be listed being taken up by the general public, and the company must publish a prospectus authorised by Oslo Børs in accordance with the Stock Exchange Regulations.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 31 October 2005.
About Bergesen Worldwide Gas
Bergesen Worldwide Gas ASA is a leading global provider of marine gas transportation services. The company is the largest owner and operator of LPG (liquefied petroleum gas) carriers and one of the largest independent owners and operators of LNG (liquefied natural gas) carriers. Bergesen Worldwide Gas owns, part-owns and/or operates a fleet of 69 vessels of which 63 are LPG vessels (transporting mainly LPG and ammonia), and six are LNG vessels. In addition the company has 4 LPG carriers and 3 LNG carriers on order. The LPG carriers are operated in the spot market or under short- to medium term time charters or contract of affreightments, whereas the large LNG carriers are operated under long-term contracts.
Bluewater Insurance to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Bluewater Insurance ASA to listing on the SMB List of Oslo Børs. The Board stipulated that prior to the first day of listing the company must, through its planned share issue, satisfy the requirements for the number of holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001. Admission to listing is also conditional on the company publishing a prospectus authorised by Oslo Børs in accordance with the Stock Exchange Regulations.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 31 October 2005.
About Bluewater Insurance
Bluewater Insurance operates in the market for insurance of ships and offshore units (the marine insurance market) and offers special solutions to selected clients. Special solutions is mainly offered in non-marine classes, but Bluewater can also design structures adopting this profile for marine classes. The company does business with companies from more than 35 countries. Bluewater have 18 employees and has its head office in Oslo.
Powel to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Powel ASA to listing on Oslo Børs. The company must publish a prospectus authorised by Oslo Børs in accordance with the Stock Exchange Regulations prior to the first day of listing.
The Board authorised the President of Oslo Børs to decide whether the company should be listed on the SMB List or the Main List and to fix the date of the first day of listing, which is to be no later than 31 October 2005.
Biotec Pharmacon to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Biotec Pharmacon ASA to listing on the SMB List of Oslo Børs ASA. The Board stipulated that prior to the first day of listing the company must, through its planned share issue, satisfy the requirements for the number of holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001. Admission to listing is also conditional on at least 25% of the shares to be listed being taken up by the general public, and the company must publish a prospectus authorised by Oslo Børs in accordance with the Stock Exchange Regulations. Moreover the Board also stipulated that the company must succeed in raising at least NOK 50 million of equity from its planned share issue in order to satisfy the requirement to have liquid assets sufficient to meet the cost of operations for at least 18 months.
The Board authorised the President of Oslo Børs to fix the date of the first day of listing, which is to be no later than 10 November 2005.
About Biotec Pharmacon
Biotec Pharmacon ASA is a biopharmaceutical company that develops and manufactures new products for treatment and prevention of diseases related to weakness or failure in the immune system. Based on own research and development, the company produces the immune-stimulating compound SBG, which enhances the body’s own ability to destroy tumour cells, repair wounds and fight infections. The company has started several clinical trials with priority on immune-therapy of cancer and treatment of chronic ulcers in humans. The company also manufactures and sells non-pharmaceuticals, including marine bio-chemicals, dietary supplements, cosmetics and animal health products, all of which contribute to financing of the company’s pharmaceutical development program.
Cermaq to be listed on Oslo Børs
The Board of Oslo Børs resolved to admit shares in Cermaq ASA to listing on Oslo Børs.
The Board stipulated that prior to the first day of listing the company must, through its planned share issue, satisfy the requirements for the number of holders of one round lot or more of the company's shares set out in Oslo Børs Circular No. 5/2001. Admission to listing is also conditional on at least 25% of the shares to be listed being taken up by the general public, and the company must publish a prospectus authorised by Oslo Børs in accordance with the Stock Exchange Regulations.
The Board authorised the President of Oslo Børs to decide whether the company should be listed on the SMB List or the Main List and to fix the date of the first day of listing, which is to be no later than 31 October 2005.
About Cermaq
Cermaq is an international group of companies with activities in fish farming, production of salmonid feed and research in aquaculture. Cermaq has operations in Norway, Scotland, Canada and Chile, the main geographic regions for salmon and trout farming. Through the EWOS group, Cermaq is a world leader in the production of salmonid feed. Fish farming is organized through the Mainstream group which is among the largest international producers of farmed salmon and trout.
The group had 2004 revenues of NOK 5 billion, and employed 3000 people.
